# The Effects of Positive Airway Pressure on the Mucolytic Effects of NAC (TEAM)

> **NCT06152653** · PHASE4 · RECRUITING · sponsor: **University of California, San Francisco** · enrollment: 40 (estimated)

## Conditions studied

- Asthma
- COPD

## Interventions

- **DRUG:** n-acetylcystine (NAC)+ albuterol
- **DEVICE:** AeroEclipse-VersaPAP System

## Key facts

- **NCT ID:** NCT06152653
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-09
- **Primary completion:** 2027-04
- **Final completion:** 2027-04
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-07-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06152653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06152653, "The Effects of Positive Airway Pressure on the Mucolytic Effects of NAC (TEAM)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06152653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*